शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSELINK PHARMA CHEM LTD.· Chemicals & PetrochemicalsHighNeutral
Announced Tue, 3 Nov, 2026 · 12:57 IST

Standalone September 2026 quarter revenue falls 15% and profit after tax turns negative

Revenue declinedNet loss reportedEBITDA margin compressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-9.8%Reaction day
₹26.00
prior close
₹24.05
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-10.0% vs market
Commodity Chemicals peers, median of 58sector+0.0%-9.8% vs sector

On the reaction day the stock moved 10.0 pts less than Nifty Microcap 250 and 9.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-9.8+0.3-10.0+0.0-9.8
Next day
-1.2+2.4-3.6+0.7-1.8
2d
-1.9+3.6-5.5+1.3-3.2
3d
-3.1pendingpending+1.1-4.2
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone revenue for the quarter ended 30 September 2026 was Rs 533.13 lakh, down 15.3% from Rs 629.32 lakh a year earlier, while profit after tax was a Rs 22.31 lakh loss versus a Rs 1.56 lakh profit. For the standalone half year ended 30 September 2026, revenue was Rs 1,409.97 lakh and profit after tax Rs 9.52 lakh, versus Rs 1,410.80 lakh and Rs 41.73 lakh a year earlier. The review identified no material concern.

Likely market impact

Lower quarterly sales and a shift to loss may pressure sentiment, but positive half-year operating cash flow and low borrowings provide support.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹5.33 Cr₹6.29 Cr−15.3%
Operating profit−₹0.20 Cr−₹0.04 Crloss widened
Profit after tax−₹0.22 Cr₹0.02 Cr−1,530.1%
EBITDA margin3.6%5.4%−1.8 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.